Breaking News
March 25, 2018 - Humanigen Completes Enrollment of Phase 1 Clinical Trial of Lenzilumab for Treatment of Chronic Myelomonocytic Leukemia
March 25, 2018 - ENDO 2018 Roundup: New Tx Options for Obesity, Low BMD, Benign Thyroid Disease
March 25, 2018 - The protein that prevents loose teeth
March 24, 2018 - Morning Break: Skip the Finger Exam? Self C-Section; Toxic Toenail Fungus
March 24, 2018 - 3-D simulations reveal synergistic mechanisms of the human heart
March 24, 2018 - Newly designed three-part molecule shows promise to treat breast cancers
March 24, 2018 - Pubertal hormones not responsible for changes in social behavior during adolescence
March 24, 2018 - Waning Vaccine Protection May Be Driving Rise in U.S. Mumps Cases
March 24, 2018 - Folic Acid in Utero Tied to Food Allergy Risk
March 24, 2018 - Trial shows safety of drugs for irregular heartbeat patients undergoing treatment
March 24, 2018 - Penn State psychologists shed light on false memories in older adults
March 24, 2018 - Patients who self-discharge should be viewed more positively, say researchers
March 24, 2018 - Wearable brain scanner enables brain imaging whilst moving
March 24, 2018 - Trump Signs $1.3 Trillion Spending Bill, Averts Shutdown
March 24, 2018 - Two drugs prevent heart problems in breast cancer patients
March 24, 2018 - Research provides better understanding of how some cancer cells resist treatment
March 24, 2018 - Certain nutrients found in food may help reduce symptoms of psychotic illness
March 24, 2018 - AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
March 24, 2018 - AHRQ Is in Trouble | Medpage Today
March 24, 2018 - Could a pap test spot more than just cervical cancer?
March 24, 2018 - Men have greater hospital readmission risk following firearm injury, study shows
March 24, 2018 - Pediatric psychologist shares 11 warning signs of childhood depression
March 24, 2018 - OncoBreak: ‘I Was Normal Once’; Ending Cervical Cancer; Mammo Controversy
March 24, 2018 - Gum Disease by the Numbers
March 24, 2018 - Studies show tool can identify individual needs, supports to help youths with autism, intellectual disabilities
March 24, 2018 - Study reveals cause of extreme nausea in pregnancy
March 24, 2018 - New findings highlight need to reconsider cervical cancer screening guidelines
March 24, 2018 - Smartwatch App Might Help Detect A-Fib
March 24, 2018 - TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis
March 24, 2018 - Kids with severe brain injuries may develop ADHD: study
March 24, 2018 - Researchers explore ways to help older adults taper off and stop using sedatives
March 24, 2018 - Back pain being mismanaged globally
March 24, 2018 - Fingerprint test accurately and noninvasively detects heroin, cocaine users
March 24, 2018 - Leading experts to promote cardiovascular health at EuroPrevent 2018
March 24, 2018 - A Role for Rituximab in Lupus?
March 24, 2018 - New osteoarthritis genes discovered
March 24, 2018 - Maternal intake of DHA supplement linked to higher fat-free body mass in children
March 24, 2018 - Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop
March 24, 2018 - Maternal alcohol use early in pregnancy may be risk factor for infant abdominal malformation
March 24, 2018 - Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
March 24, 2018 - Accelerated WBI Should be the Norm for Most Breast Cancers
March 24, 2018 - Experts seek to standardize treatments for childhood rheumatic diseases
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Researchers identify chemical responsible for carcinogen formation in recycled wastewater
March 24, 2018 - Obesity and severe obesity continue to rise among U.S. adults
March 24, 2018 - Missed hospital appointments increase after spring clock change in the UK
March 24, 2018 - Researchers explore ways to manage and prevent falls in older adults with dementia
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - NUST MISIS researchers produce elastic metal rods for scoliosis treatment
March 24, 2018 - New University of Bath project seeks to make injections safer
March 24, 2018 - Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
March 23, 2018 - Researchers identify potential obesity treatment in freezing hunger-signaling nerve
March 23, 2018 - Wales participates in the 100,000 Genomes Project
10 MM: Better for Predicting LN Mets in Appendiceal NETs?

10 MM: Better for Predicting LN Mets in Appendiceal NETs?

image_pdfDownload PDFimage_print

Action Points

  • Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
  • When predicting lymph node metastasis in appendiceal, well-differentiated neuroendocrine tumors (WDNETs), researchers here suggested a tumor size threshold of 10 mm compared with the traditional 20 mm.
  • Note that patients with regionally advanced well-differentiated neuroendocrine tumors have favorable prognosis regardless of type of surgery, while patients with mixed histology tumors with lymph node involvement had significantly worse survival compared to well differentiated neuroendocrine tumors.

PHILADELPHIA — When predicting lymph node metastasis in appendiceal, well-differentiated neuroendocrine tumors (WDNETs), researchers here suggested a tumor size threshold of 10 mm compared with the traditional 20 mm.

WDNETs between the size of 11 mm to 20 mm had higher rates of lymph node involvements compared to those ≤10 mm, following adequate dissection of 12 or more lymph nodes (56.8% versus 11.6%, P<0.001), according to Amir Mehrvarz Sarshekeh, MD, of the MD Anderson Cancer Center in Houston, and colleagues.

Similarly findings were reported for mixed histology tumors (MHTs) between 11-20 mm in size (32.9% versus 10.4%, P=0.004), they reported in a presentation at the North American Neuroendocrine Tumor Society annual symposium.

“Neuroendocrine tumors of appendix are usually found incidentally during appendectomy,” Mehrvarz Sarshekeh and co-author Arvind Dasari, MD, also of MD Anderson, said jointly in an email to MedPage Today. “At that time, clinicians usually face a challenge to consider appendectomy sufficient or to proceed with right hemicolectomy. The decision is usually based on the risk of regional lymph node involvement and/or metastatic disease. Tumor size is the principal factor and cut-off of 20 mm for right hemicolectomy has been accepted to formulate our treatment guidelines.

“This cut-off is based on small retrospective studies performed on carcinoid tumors of appendix,” they continued. “Since the sub-classification of appendiceal carcinoid tumors in 2010, the cut off has not been validated in different histologic subtypes and in large population-based databases. Also, the outcomes of right hemicolectomy in regionally advanced disease is unclear.”

The authors collected data on 1,731 patients from the SEER database, classified by histology codes. The analysis included 860 WDNET cases (38.0%), which mostly comprised of low-grade neuroendocrine tumors. A total of 1,659 MHT cases were assessed (60.8%) — which had tumors with both neuroendocrine and epithelial components — consisting of goblet cell carcinoid, mixed adenoneuroendocrine carcinoma, and adenocarcinoid tumors. Poorly-differentiated neuroendocrine carcinomas (PDNECs) accounted for 1.2% of appendiceal NET subtypes included (n=26).

Node-positive disease was defined in the study as any pathologic lymph node involvement, while node-negative disease was classified as no involvement after a surgical assessment of at least 12 lymph nodes. A total of 19.2% of all patients had lymph node involvement.

In a comparison of tumor subtypes, patients with WDNETs tended to be younger than those with MHT (median age 42 versus 56, P<0.001). MHT patients tended to have more distant metastases compared to WDNET cases (12.3% versus 4.8%, P<0.001).

Among the appendiceal NET histologic subtypes, 10-year cancer-specific survival rates were as follow:

  • WDNETs: 92.6%
  • MHTs: 78.1%
  • PDNECs: 0%

In an adjusted multivariable analysis, the following characteristics were significant (all P<0.001) in association with poorer cancer-specific survival in cases without any distant metastases:

  • MHT vs WDNET: HR 15.77 (95% CI 6.81-36.53)
  • Age >65 at diagnoses: HR 2.18 (95% CI 1.42-3.36)
  • Node involvement: HR 11.41 (95% CI 7.64-17.04)

However, the type of surgery — right hemicolectomy versus simple appendectomy — was not tied to cancer-specific survival (HR 1.12, 95% CI 0.72-1.73, P<0.62).

“We also observed that patients with regionally advanced well-differentiated neuroendocrine tumors have favorable prognosis regardless of type of surgery, while patients with mixed histology tumors with lymph node involvement had significantly worse survival compared to well differentiated neuroendocrine tumors,” Mehrvarz Sarshekeh and Dasari stated. “Our study confirms the findings of smaller studies with regards to risk of lymph node involvement and further builds on them by adding on the survival data.”

In terms of future research, the authors recommended studies that would confirm and validate their findings utilizing databases, and that “carefully designed prospective studies in both histological subtypes” are needed as well, they suggested.

“Also, the role of adjuvant therapy in mixed histology tumors needs to evaluated,” they said. “Until then, the need for right hemicolectomy in patients with well differentiated appendiceal neuroendocrine tumors should be personalized.”

No funding information was provided. Sarshekeh reported no relevant conflicts of interest.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner


last updated

Tagged with:

About author

Related Articles